- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: R.347, Q.351
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.7: 5 residues within 4Å:- Chain A: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.9: 5 residues within 4Å:- Chain A: K.323, Y.420, R.515
- Chain H: R.509
- Ligands: SO4.10
Ligand excluded by PLIPSO4.10: 5 residues within 4Å:- Chain A: L.514, R.515, Q.518
- Chain H: R.509
- Ligands: SO4.9
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain B: R.347, Q.351
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain B: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain B: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.27: 5 residues within 4Å:- Chain B: K.323, Y.420, R.515
- Chain F: R.509
- Ligands: SO4.28
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain B: L.514, R.515, Q.518
- Chain F: R.509
- Ligands: SO4.27
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain C: R.347, Q.351
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain C: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.43: 5 residues within 4Å:- Chain C: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.45: 5 residues within 4Å:- Chain C: K.323, Y.420, R.515
- Chain E: R.509
- Ligands: SO4.46
Ligand excluded by PLIPSO4.46: 5 residues within 4Å:- Chain C: L.514, R.515, Q.518
- Chain E: R.509
- Ligands: SO4.45
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain D: R.347, Q.351
Ligand excluded by PLIPSO4.60: 4 residues within 4Å:- Chain D: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.61: 5 residues within 4Å:- Chain D: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.63: 5 residues within 4Å:- Chain D: K.323, Y.420, R.515
- Chain G: R.509
- Ligands: SO4.64
Ligand excluded by PLIPSO4.64: 5 residues within 4Å:- Chain D: L.514, R.515, Q.518
- Chain G: R.509
- Ligands: SO4.63
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain E: R.347, Q.351
Ligand excluded by PLIPSO4.78: 4 residues within 4Å:- Chain E: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.79: 5 residues within 4Å:- Chain E: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.81: 5 residues within 4Å:- Chain C: R.509
- Chain E: K.323, Y.420, R.515
- Ligands: SO4.82
Ligand excluded by PLIPSO4.82: 5 residues within 4Å:- Chain C: R.509
- Chain E: L.514, R.515, Q.518
- Ligands: SO4.81
Ligand excluded by PLIPSO4.92: 2 residues within 4Å:- Chain F: R.347, Q.351
Ligand excluded by PLIPSO4.96: 4 residues within 4Å:- Chain F: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.97: 5 residues within 4Å:- Chain F: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.99: 5 residues within 4Å:- Chain B: R.509
- Chain F: K.323, Y.420, R.515
- Ligands: SO4.100
Ligand excluded by PLIPSO4.100: 5 residues within 4Å:- Chain B: R.509
- Chain F: L.514, R.515, Q.518
- Ligands: SO4.99
Ligand excluded by PLIPSO4.110: 2 residues within 4Å:- Chain G: R.347, Q.351
Ligand excluded by PLIPSO4.114: 4 residues within 4Å:- Chain G: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.115: 5 residues within 4Å:- Chain G: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.117: 5 residues within 4Å:- Chain D: R.509
- Chain G: K.323, Y.420, R.515
- Ligands: SO4.118
Ligand excluded by PLIPSO4.118: 5 residues within 4Å:- Chain D: R.509
- Chain G: L.514, R.515, Q.518
- Ligands: SO4.117
Ligand excluded by PLIPSO4.128: 2 residues within 4Å:- Chain H: R.347, Q.351
Ligand excluded by PLIPSO4.132: 4 residues within 4Å:- Chain H: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.133: 5 residues within 4Å:- Chain H: W.231, R.242, L.286, S.287, V.288
Ligand excluded by PLIPSO4.135: 5 residues within 4Å:- Chain A: R.509
- Chain H: K.323, Y.420, R.515
- Ligands: SO4.136
Ligand excluded by PLIPSO4.136: 5 residues within 4Å:- Chain A: R.509
- Chain H: L.514, R.515, Q.518
- Ligands: SO4.135
Ligand excluded by PLIP- 8 x NA: SODIUM ION(Non-functional Binders)
NA.3: 3 residues within 4Å:- Chain A: F.525
- Chain C: F.521, F.525
No protein-ligand interaction detected (PLIP)NA.21: 3 residues within 4Å:- Chain B: F.525
- Chain D: F.521, F.525
No protein-ligand interaction detected (PLIP)NA.39: 3 residues within 4Å:- Chain A: F.521, F.525
- Chain C: F.525
No protein-ligand interaction detected (PLIP)NA.57: 3 residues within 4Å:- Chain B: F.521, F.525
- Chain D: F.525
No protein-ligand interaction detected (PLIP)NA.75: 3 residues within 4Å:- Chain E: F.525
- Chain G: F.521, F.525
No protein-ligand interaction detected (PLIP)NA.93: 3 residues within 4Å:- Chain F: F.525
- Chain H: F.521, F.525
No protein-ligand interaction detected (PLIP)NA.111: 3 residues within 4Å:- Chain E: F.521, F.525
- Chain G: F.525
No protein-ligand interaction detected (PLIP)NA.129: 3 residues within 4Å:- Chain F: F.521, F.525
- Chain H: F.525
No protein-ligand interaction detected (PLIP)- 8 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 3 residues within 4Å:- Chain A: S.487, T.488, T.508
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain B: S.487, T.488, T.508
Ligand excluded by PLIPCL.40: 3 residues within 4Å:- Chain C: S.487, T.488, T.508
Ligand excluded by PLIPCL.58: 3 residues within 4Å:- Chain D: S.487, T.488, T.508
Ligand excluded by PLIPCL.76: 3 residues within 4Å:- Chain E: S.487, T.488, T.508
Ligand excluded by PLIPCL.94: 3 residues within 4Å:- Chain F: S.487, T.488, T.508
Ligand excluded by PLIPCL.112: 3 residues within 4Å:- Chain G: S.487, T.488, T.508
Ligand excluded by PLIPCL.130: 3 residues within 4Å:- Chain H: S.487, T.488, T.508
Ligand excluded by PLIP- 8 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 6 residues within 4Å:- Chain A: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.98, A:K.131
GOL.23: 6 residues within 4Å:- Chain B: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.98, B:K.131
GOL.41: 6 residues within 4Å:- Chain C: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:W.98, C:K.131
GOL.59: 6 residues within 4Å:- Chain D: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:W.98, D:K.131
GOL.77: 6 residues within 4Å:- Chain E: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:W.98, E:K.131
GOL.95: 6 residues within 4Å:- Chain F: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:W.98, F:K.131
GOL.113: 6 residues within 4Å:- Chain G: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:W.98, G:K.131
GOL.131: 6 residues within 4Å:- Chain H: M.16, L.18, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:W.98, H:K.131
- 56 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Non-covalent)
NAG.8: 1 residues within 4Å:- Ligands: NAG-FUC.1
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: N.106, N.188, K.190
- Ligands: FUC.12
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: R.14, N.57
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.256, T.258
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: Y.237, N.241, N.245
- Ligands: NAG.17
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: K.248
- Ligands: NAG.16, FUC.18
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Ligands: NAG-FUC.19
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain B: N.106, N.188, K.190
- Ligands: FUC.30
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: R.14, N.57
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.256, T.258
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: Y.237, N.241, N.245
- Ligands: NAG.35
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: K.248
- Ligands: NAG.34, FUC.36
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Ligands: NAG-FUC.37
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain C: N.106, N.188, K.190
- Ligands: FUC.48
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: R.14, N.57
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain C: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: N.256, T.258
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain C: Y.237, N.241, N.245
- Ligands: NAG.53
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: K.248
- Ligands: NAG.52, FUC.54
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Ligands: NAG-FUC.55
Ligand excluded by PLIPNAG.65: 4 residues within 4Å:- Chain D: N.106, N.188, K.190
- Ligands: FUC.66
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Chain D: R.14, N.57
Ligand excluded by PLIPNAG.68: 4 residues within 4Å:- Chain D: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.69: 2 residues within 4Å:- Chain D: N.256, T.258
Ligand excluded by PLIPNAG.70: 4 residues within 4Å:- Chain D: Y.237, N.241, N.245
- Ligands: NAG.71
Ligand excluded by PLIPNAG.71: 3 residues within 4Å:- Chain D: K.248
- Ligands: NAG.70, FUC.72
Ligand excluded by PLIPNAG.80: 1 residues within 4Å:- Ligands: NAG-FUC.73
Ligand excluded by PLIPNAG.83: 4 residues within 4Å:- Chain E: N.106, N.188, K.190
- Ligands: FUC.84
Ligand excluded by PLIPNAG.85: 2 residues within 4Å:- Chain E: R.14, N.57
Ligand excluded by PLIPNAG.86: 4 residues within 4Å:- Chain E: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.87: 2 residues within 4Å:- Chain E: N.256, T.258
Ligand excluded by PLIPNAG.88: 4 residues within 4Å:- Chain E: Y.237, N.241, N.245
- Ligands: NAG.89
Ligand excluded by PLIPNAG.89: 3 residues within 4Å:- Chain E: K.248
- Ligands: NAG.88, FUC.90
Ligand excluded by PLIPNAG.98: 1 residues within 4Å:- Ligands: NAG-FUC.91
Ligand excluded by PLIPNAG.101: 4 residues within 4Å:- Chain F: N.106, N.188, K.190
- Ligands: FUC.102
Ligand excluded by PLIPNAG.103: 2 residues within 4Å:- Chain F: R.14, N.57
Ligand excluded by PLIPNAG.104: 4 residues within 4Å:- Chain F: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.105: 2 residues within 4Å:- Chain F: N.256, T.258
Ligand excluded by PLIPNAG.106: 4 residues within 4Å:- Chain F: Y.237, N.241, N.245
- Ligands: NAG.107
Ligand excluded by PLIPNAG.107: 3 residues within 4Å:- Chain F: K.248
- Ligands: NAG.106, FUC.108
Ligand excluded by PLIPNAG.116: 1 residues within 4Å:- Ligands: NAG-FUC.109
Ligand excluded by PLIPNAG.119: 4 residues within 4Å:- Chain G: N.106, N.188, K.190
- Ligands: FUC.120
Ligand excluded by PLIPNAG.121: 2 residues within 4Å:- Chain G: R.14, N.57
Ligand excluded by PLIPNAG.122: 4 residues within 4Å:- Chain G: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.123: 2 residues within 4Å:- Chain G: N.256, T.258
Ligand excluded by PLIPNAG.124: 4 residues within 4Å:- Chain G: Y.237, N.241, N.245
- Ligands: NAG.125
Ligand excluded by PLIPNAG.125: 3 residues within 4Å:- Chain G: K.248
- Ligands: NAG.124, FUC.126
Ligand excluded by PLIPNAG.134: 1 residues within 4Å:- Ligands: NAG-FUC.127
Ligand excluded by PLIPNAG.137: 4 residues within 4Å:- Chain H: N.106, N.188, K.190
- Ligands: FUC.138
Ligand excluded by PLIPNAG.139: 2 residues within 4Å:- Chain H: R.14, N.57
Ligand excluded by PLIPNAG.140: 4 residues within 4Å:- Chain H: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.141: 2 residues within 4Å:- Chain H: N.256, T.258
Ligand excluded by PLIPNAG.142: 4 residues within 4Å:- Chain H: Y.237, N.241, N.245
- Ligands: NAG.143
Ligand excluded by PLIPNAG.143: 3 residues within 4Å:- Chain H: K.248
- Ligands: NAG.142, FUC.144
Ligand excluded by PLIP- 16 x FUC: alpha-L-fucopyranose(Non-covalent)
FUC.12: 6 residues within 4Å:- Chain A: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.11
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.188, A:S.191, A:R.219
- Water bridges: A:T.108, A:S.191, A:S.191
FUC.18: 5 residues within 4Å:- Chain A: N.245, K.248, F.278, V.280
- Ligands: NAG.17
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:N.245
- Hydrogen bonds: A:K.248, A:F.278
FUC.30: 6 residues within 4Å:- Chain B: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.29
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.188, B:S.191, B:R.219
- Water bridges: B:S.191, B:S.191
FUC.36: 5 residues within 4Å:- Chain B: N.245, K.248, F.278, V.280
- Ligands: NAG.35
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:N.245
- Hydrogen bonds: B:K.248, B:F.278
FUC.48: 6 residues within 4Å:- Chain C: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.47
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:N.188, C:S.191, C:R.219
- Water bridges: C:S.191, C:S.191
FUC.54: 5 residues within 4Å:- Chain C: N.245, K.248, F.278, V.280
- Ligands: NAG.53
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:N.245
- Hydrogen bonds: C:K.248, C:F.278
FUC.66: 6 residues within 4Å:- Chain D: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.65
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:N.188, D:S.191, D:R.219
- Water bridges: D:T.108, D:S.191, D:S.191
FUC.72: 5 residues within 4Å:- Chain D: N.245, K.248, F.278, V.280
- Ligands: NAG.71
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:N.245
- Hydrogen bonds: D:K.248, D:F.278
FUC.84: 6 residues within 4Å:- Chain E: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.83
6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:N.188, E:S.191, E:R.219
- Water bridges: E:T.108, E:S.191, E:S.191
FUC.90: 5 residues within 4Å:- Chain E: N.245, K.248, F.278, V.280
- Ligands: NAG.89
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:N.245
- Hydrogen bonds: E:K.248, E:F.278
FUC.102: 6 residues within 4Å:- Chain F: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.101
6 PLIP interactions:6 interactions with chain F- Hydrogen bonds: F:N.188, F:S.191, F:R.219
- Water bridges: F:T.108, F:S.191, F:S.191
FUC.108: 5 residues within 4Å:- Chain F: N.245, K.248, F.278, V.280
- Ligands: NAG.107
3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:N.245
- Hydrogen bonds: F:K.248, F:F.278
FUC.120: 6 residues within 4Å:- Chain G: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.119
5 PLIP interactions:5 interactions with chain G- Hydrogen bonds: G:N.188, G:S.191, G:R.219
- Water bridges: G:S.191, G:S.191
FUC.126: 5 residues within 4Å:- Chain G: N.245, K.248, F.278, V.280
- Ligands: NAG.125
3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:N.245
- Hydrogen bonds: G:K.248, G:F.278
FUC.138: 6 residues within 4Å:- Chain H: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.137
5 PLIP interactions:5 interactions with chain H- Hydrogen bonds: H:N.188, H:S.191, H:R.219
- Water bridges: H:S.191, H:S.191
FUC.144: 5 residues within 4Å:- Chain H: N.245, K.248, F.278, V.280
- Ligands: NAG.143
3 PLIP interactions:3 interactions with chain H- Hydrophobic interactions: H:N.245
- Hydrogen bonds: H:K.248, H:F.278
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-Ray Structure Analysis. Chem.Res.Toxicol. (2011)
- Release Date
- 2011-06-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 56 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Non-covalent)
- 16 x FUC: alpha-L-fucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-Ray Structure Analysis. Chem.Res.Toxicol. (2011)
- Release Date
- 2011-06-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A